Yüklüyor......
Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
Many studies have shown evidence that erythropoiesis-stimulating agents (ESAs), as a classic treatment for chronic kidney disease (CKD)-related anemia, have several disadvantages and may trigger various adverse events with long-term use. The hypoxia-induced factor (HIF) pathway has been intensively...
Kaydedildi:
| Yayımlandı: | Front Med (Lausanne) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5786558/ https://ncbi.nlm.nih.gov/pubmed/29404328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00259 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|